Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $50.9200 (1.13%) ($50.9200 - $50.9200) on Tue. Jan. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.53% (three month average) | RSI | 24 | Latest Price | $50.9200(1.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.6% a day on average for past five trading days. | Weekly Trend | HALO declines -5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(37%) XBI(36%) IFRA(34%) IWO(31%) IWM(30%) | Factors Impacting HALO price | HALO will decline at least -1.265% in a week (0% probabilities). VXX(-15%) VIXM(-12%) IGOV(-12%) UUP(-10%) GLD(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.265% (StdDev 2.53%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $43.41(-14.75%) | Resistance Level | $55.02 | 5 Day Moving Average | $51.6(-1.32%) | 10 Day Moving Average | $53.08(-4.07%) | 20 Day Moving Average | $55.02(-7.45%) | To recent high | -14.2% | To recent low | 16% | Market Cap | $6.959b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |